drugset / Trial / NCT00370370
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
RandomizedParallel-groupSingle-blindTreatment
Summary
To compare the efficacy and safety results of intravitreal bevacizumab alone with bevacizumab + triamcinolone acetonide in neovascular AMD.
Timeline
- Start
- 2005-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | — | Intravitreal |
| Comparator | Triamcinolone Acetonide | Other / unclassified | — | — |